Morgan Stanley Cue Health Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Cue Health Inc. stock. As of the latest transaction made, Morgan Stanley holds 17,304 shares of HLTH stock, worth $173. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,304

Previous 20,507 15.62%

Holding current value

$173

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.18 - $0.32 $576 - $1,024	-3,203 Reduced 15.62%	17,304 $3,000
Q4 2023 Feb 13, 2024	SELL	$0.16 - $0.44 $6,560 - $18,041	-41,003 Reduced 66.66%	20,507 $3,000
Q3 2023 Nov 15, 2023	SELL	$0.34 - $0.65 $83,926 - $160,448	-246,844 Reduced 80.05%	61,510 $27,000
Q2 2023 Aug 14, 2023	BUY	$0.37 - $1.88 $63,685 - $323,589	172,122 Added 126.34%	308,354 $114,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.7 $1,114 - $1,719	637 Added 0.47%	136,232 $247,000

Q4 2022 Feb 14, 2023	BUY	$1.72 - $4.1 $129,835 - $309,492	75,486 Added 125.58%	135,595 $280,000
Q3 2022 Nov 14, 2022	SELL	$2.92 - $4.88 $73,455 - $122,761	-25,156 Reduced 29.5%	60,109 $181,000
Q2 2022 Oct 27, 2022	BUY	$3.2 - $7.0 $187,001 - $409,066	58,438 Added 217.83%	85,265 $272,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $7.0 $187,001 - $409,066	58,438 Added 217.83%	85,265 $272,000
Q1 2022 Oct 27, 2022	SELL	$6.45 - $14.67 $376,925 - $857,285	-58,438 Reduced 68.54%	26,827 $174,000
Q1 2022 May 13, 2022	BUY	$6.45 - $14.67 $40,880 - $92,978	6,338 Added 30.93%	26,827 $174,000
Q4 2021 Feb 14, 2022	BUY	$8.92 - $15.66 $165,608 - $290,743	18,566 Added 965.47%	20,489 $274,000
Q3 2021 Nov 15, 2021	BUY	$11.81 - $20.0 $22,710 - $38,460	1,923 New	1,923 $23,000

Others Institutions Holding HLTH

# of Institutions

Shares Held

66.6M

Call Options Held

Put Options Held

View Full List

About Cue Health Inc.

Ticker HLTH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 148,152,992
Market Cap $1.48M
Description
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...

More about HLTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account